login
login

Europe Daily Bulletin No. 12979

25 June 2022
Contents Publication in full By article 25 / 28
NEWS BRIEFS / Health
EMA recommends authorisation of Valneva’s Covid-19 vaccine

24/06/2022 (Agence Europe)The European Medicines Agency (EMA) recommended, on Thursday 23 June, a conditional marketing authorisation for the SARS-CoV-2 vaccine developed by the firm Valneva. This developed inactivated whole virus vaccine is the sixth vaccine recommended by the EMA. The vaccine is currently recommended for adults between the ages of 18 and 50. The EMA states that the vaccine dossier contains the results of an immunobridging trial. Placebo-controlled efficacy trials...

Contents

EUROPEAN COUNCIL
EXTERNAL ACTION
SECTORAL POLICIES
Russian invasion of Ukraine
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
EUROPEAN PARLIAMENT PLENARY
NEWS BRIEFS